Prevalence of Dysbiosis in HNC patients and the Control Group
| Group | Dysbiosis Yes | Dysbiosis No | Total | Prevalence (%) | 95% CI |
|---|---|---|---|---|---|
| HNC | 36 | 152 | 188 | 19.8 | 13.8–25.5 |
| Controls | 30 | 46 | 76 | 40.0 | 28.4–51.4 |
| Group | Dysbiosis Yes | Dysbiosis No | Total | Prevalence (%) | 95% CI |
|---|---|---|---|---|---|
| HNC | 36 | 152 | 188 | 19.8 | 13.8–25.5 |
| Controls | 30 | 46 | 76 | 40.0 | 28.4–51.4 |
© 2025 Piotr Nogal, Małgorzata Wierzbicka, Natalia Zagozda, Joanna Jackowska, published by Hirszfeld Institute of Immunology and Experimental Therapy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.